Author
Listed:
- Elias E. Mazokopakis
(Naval Hospital of Crete, Greece)
- Maria G. Papadomanolaki
(Technical University of Crete, Greece)
Abstract
Background & Aims: Spirulina is a filamentous cyanobacterium known for its high nutritional value and therapeutic properties. The aim of this study was to investigate the role of Spirulina supplementation on coronavirus disease 2019 (COVID-19) prevention and hospitalization. Methods: We studied the state of health among 186 (median age: 47, range: 30-60 years) Greek individuals, non-vaccinated against the COVID-19, for 6 months. Among these, 102 unvaccinated individuals received orally 6 g Spirulina (Arthrospira platensis) daily for 6 months. Anthropometric characteristics (height, weight, body mass index / BMI), systolic and diastolic blood pressure, complete blood count and biochemical assessments, were recorded and measured before Spirulina supplementation. Results: Among the 102 unvaccinated individuals who received Spirulina, only 14 (13.7%) contracted SARS-CoV2 (confirmed Delta variant) with mild symptoms and 2 (1.9%) needed hospitalization because of acute viral gastroenteritis. In contrast, among the 84 unvaccinated individuals who did not receive Spirulina, 62 (73.8%) contracted SARS-CoV2 (confirmed Delta variant) with mild symptoms and 17 (20.2%) needed hospitalization. None of the hospitalized patients died. Conclusions: Spirulina supplementation at a dose of 6 g daily can contribute to the war against SARS-CoV2, preventing COVID-19 and reducing the need for hospitalization.
Suggested Citation
Elias E. Mazokopakis & Maria G. Papadomanolaki, 2022.
"The Contribution of Spirulina Platensis Supplementation on COVID-19 Prevention and Hospitalization,"
European Journal of Medical and Health Sciences, European Open Science, vol. 4(3), pages 82-83, May.
Handle:
RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41355
DOI: 10.24018/ejmed.2022.4.3.1355
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41355. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.